Skip to content
Home
Biosector Blog
Home
Biosector Blog
Posts in oncology CRO
by
Stefan Sandström
September 21, 2026
Daiichi Sankyo Collaboration Opportunities Beyond ADCs
I often hear that Daiichi Sankyo is only available as an ADC partner. This, however, is […]
0
read more
by
Stefan Sandström
August 10, 2026
Daiichi Sankyo ADC strategy: Where Your New Opportunities Lie
Daiichi Sankyo has built one of the pharmaceutical industry’s most productive antibody-drug conjugate platforms. Enhertu has […]
0
read more